
You can purchase shares of HANGZHOU TIGERMED by HANGZHOU TIGERMED CONSULTING CO LTD. (OTCPK:HTMDF) through any online brokerage.
There are no as such competitors for HANGZHOU TIGERMED by HANGZHOU TIGERMED CONSULTING CO LTD..
There is no analysis for HANGZHOU TIGERMED by HANGZHOU TIGERMED CONSULTING CO LTD. to provide a consensus price target.
The stock price for HANGZHOU TIGERMED by HANGZHOU TIGERMED CONSULTING CO LTD. (OTCPK: HTMDF) is $ last updated December 31, 1969 at 7:00 PM EST.
There are no upcoming dividends for HANGZHOU TIGERMED by HANGZHOU TIGERMED CONSULTING CO LTD..
HANGZHOU TIGERMED by HANGZHOU TIGERMED CONSULTING CO LTD. does not have any upcoming earnings scheduled.
There is no upcoming split for HANGZHOU TIGERMED by HANGZHOU TIGERMED CONSULTING CO LTD..
HANGZHOU TIGERMED by HANGZHOU TIGERMED CONSULTING CO LTD. is in the Health Care sector and Life Sciences Tools & Services industry. They are listed on the OTCPK.
Hangzhou Tigermed Consulting Co Ltd is a China-based provider of comprehensive biopharmaceutical R&D services, with an expanding world-wide presence. The Group is principally engaged in CRO services.